MedTrace Logo

Effects of Infliximab (Remicade) on Fat Free Mass in Patients With Moderate to Severe COPD Suffering From Cachexia

NCT00244192 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 16

Last updated 2005-12-09

No results posted yet for this study

Summary

The purpose of this study is to determine whether infliximab is effective on fat-free mass in the treatment of patients with moderate to severe COPD suffering from cachexia.

Conditions

Interventions

DRUG

infliximab (Remicade)

Sponsors & Collaborators

  • Centocor, Inc.

    collaborator INDUSTRY

  • Center for Integrated Rehabilitation and Organ Failure Horn

    lead OTHER

Principal Investigators

  • Emiel FM Wouters, PhD, MD · University Hospital Maastricht, Department of Respiratory Medicine

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
40 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2003-10-31
Completion
2005-12-31

Countries

  • Netherlands

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00244192 on ClinicalTrials.gov